APA Zitierstil

Marmorino, F., Falcone, A., & Cremolini, C. (2019). Bevacizumab as maintenance therapy in mCRC: Interpreting results of the MOMA trial. Oncotarget.

Chicago Zitierstil

Marmorino, Federica, Alfredo Falcone, und Chiara Cremolini. "Bevacizumab As Maintenance Therapy in MCRC: Interpreting Results of the MOMA Trial." Oncotarget 2019.

MLA Zitierstil

Marmorino, Federica, Alfredo Falcone, und Chiara Cremolini. "Bevacizumab As Maintenance Therapy in MCRC: Interpreting Results of the MOMA Trial." Oncotarget 2019.

Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.